Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$2.77 USD
+0.03 (1.09%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $2.76 -0.01 (-0.36%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.07 |
Last EPS Surprise | 53.33% |
ABR | 1.33 |
Earnings ESP
|
57.14% |
---|---|
Current Year | -0.22 |
Next Year | -0.09 |
EPS (TTM) | -0.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 32.00M | 33.00M | 143.25M | 173.10M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 33.10M | 33.70M | 148.50M | 175.00M |
Low Estimate | 30.90M | 32.30M | 138.00M | 171.20M |
Year ago Sales | 29.62M | 31.76M | 127.04M | 143.25M |
Year over Year Growth Est. | 8.04% | 3.90% | 12.76% | 20.84% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.06 | -0.22 | -0.09 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.03 | -0.03 | -0.09 | -0.02 |
Low Estimate | -0.11 | -0.09 | -0.35 | -0.15 |
Year ago EPS | -0.27 | -0.35 | -0.80 | -0.22 |
Year over Year Growth Est. | 74.07% | 82.86% | 72.50% | 61.36% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.06 | -0.22 | -0.09 |
7 Days Ago | -0.07 | -0.06 | -0.22 | -0.09 |
30 Days Ago | -0.11 | -0.09 | -0.48 | -0.26 |
60 Days Ago | -0.11 | -0.09 | -0.38 | -0.26 |
90 Days Ago | NA | NA | -0.40 | -0.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.03 | -0.03 | -0.09 | -0.02 |
Zacks Consensus Estimate | -0.07 | -0.06 | -0.22 | -0.09 |
Earnings ESP | 57.14% | 50.00% | 59.09% | 76.47% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.07 | -0.17 | -0.35 | -0.27 | NA |
Estimate | -0.15 | -0.31 | -0.23 | -0.17 | NA |
Difference | 0.08 | 0.14 | -0.12 | -0.10 | 0.00 |
Surprise | 53.33% | 45.16% | -52.17% | -58.82% | -3.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more